HOPE用于儿童:低温氧合灌注成功实现儿童DCD心脏移植
该研究开发了猪DCD-HOPE模型并临床应用于6例儿童供心(3例DCD、3例脑死亡捐献),供者年龄16个月至13岁,最小体重9kg。DCD组中位功能性热缺血时间19分钟,无严重原发性移植物功能障碍,中位随访287.5天生存率100%,超声示收缩功能正常。结论认为HOPE为儿童乃至新生儿DCD供心提供了解决方案。
要点
- HOPE可成功回收、灌注并移植最小9kg供者的儿童心脏。
- DCD组中位功能性热缺血时间19分钟,无严重原发性移植物功能障碍。
- 中位随访287.5天生存率100%,收缩功能正常。
核心结论
- HOPE可为儿童乃至新生儿DCD供心提供可行方案,改善儿童供受体公平性。
研究设计与样本
- 临床系列为6例儿童供心(3例DCD、3例脑死亡捐献)经HOPE保存并移植,供者年龄16个月至13岁。
- 临床前建立猪DCD-HOPE模型模拟新生儿和婴儿心脏回收、保存与移植,含功能评估。
主要发现
- 猪婴儿心脏可成功回收、灌注并移植,旁路后心输出量良好。
- 临床中最小9kg供者心脏成功回收、灌注并移植。
- DCD组中位功能性热缺血时间19分钟,无严重原发性移植物功能障碍。
- 中位随访287.5天生存率100%,超声心动图示收缩功能正常。
关键数值与推荐
- DCD组中位功能性热缺血时间19分钟。
- 随访中位287.5天,生存率100%。
- 小供者需使用儿科研究插管及弓部加宽等外科技术。
临床怎么用
- 对儿童DCD供心可考虑采用HOPE进行回收与保存,包括小体重供者。
- 需配备儿科研究插管并掌握弓部加宽等外科技术以支持小供者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The number of children referred for advanced heart failure management is increasing and with it the demand for heart transplant. However, transplantation rates have declined and waiting list mortality is up to 25%. While donation after circulatory death (DCD) heart recovery has increased adult transplant activity significantly, barriers have prevented the same in pediatrics. In the UK and Belgium, we have adopted hypothermic oxygenated perfusion (HOPE) to address this inequity. METHODS: Preclinical: A porcine DCD-HOPE model was developed to simulate neonatal and infant heart recovery, preservation, and transplantation, including functional assessment. CLINICAL: Hearts were recovered from 6 pediatric donors (3 DCD and 3 donation after brainstem death), aged 16 months-13 years), preserved with HOPE and transplanted. For small donors, this required a pediatric research cannula and surgical techniques, such as arch augmentation. RESULTS: In the preclinical model, porcine infant hearts could be successfully recovered, perfused, and transplanted with good cardiac output postbypass. In the clinical series, hearts from donors as small as 9 kg were successfully recovered, perfused, and transplanted. For the DCD cohort, median functional warm ischemic time was 19 minutes and there was no severe primary graft dysfunction. Survival at follow-up (median 287.5 days) was 100% and echocardiograms showed normal systolic function. CONCLUSIONS: There is great need to facilitate DCD heart recovery for infants and neonates. We have reported our outcomes from the world's first and smallest pediatric DCD-HOPE heart transplants and demonstrated that HOPE provides the long-awaited solution for pediatric DCD donation down to even neonatal donors. We call upon clinicians and policymakers to support DCD-HOPE to provide equity for child donors and recipients.
引用
- Chilvers NJS, Vandendriessche K, Moeslund N, et al. HOPE for children: successful pediatric DCD heart transplantation using hypothermic oxygenated perfusion. J Heart Lung Transplant. 2025. PMID: 41061873. doi:10.1016/j.healun.2025.09.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。